• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Global regulatory agility during covid-19 and other health emergencies.

作者信息

Mak Tippi K, Lim John Cw, Thanaphollert Prapassorn, Mahlangu Gugu N, Cooke Emer, Lumpkin Murray M

机构信息

Centre of Regulatory Excellence, Duke-NUS Medical School, Singapore.

SingHealth Duke-NUS Global Health Institute, Singapore.

出版信息

BMJ. 2020 Apr 27;369:m1575. doi: 10.1136/bmj.m1575.

DOI:10.1136/bmj.m1575
PMID:32340997
Abstract
摘要

相似文献

1
Global regulatory agility during covid-19 and other health emergencies.新冠疫情及其他卫生紧急情况期间的全球监管灵活性。
BMJ. 2020 Apr 27;369:m1575. doi: 10.1136/bmj.m1575.
2
COVID-19: Not a Simple Public Health Emergency.新冠疫情：并非一场简单的突发公共卫生事件。
Prehosp Disaster Med. 2020 Apr;35(2):119. doi: 10.1017/S1049023X2000031X.
3
One world, one health: The novel coronavirus COVID-19 epidemic.同一个世界，同一份健康：新型冠状病毒COVID-19疫情。
Med Clin (Barc). 2020 Mar 13;154(5):175-177. doi: 10.1016/j.medcli.2020.02.002. Epub 2020 Feb 21.
4
Ensuring global access to COVID-19 vaccines.确保全球能够获得新冠疫苗。
Lancet. 2020 May 2;395(10234):1405-1406. doi: 10.1016/S0140-6736(20)30763-7. Epub 2020 Mar 31.
5
Covid-19 risks and response in South Asia.南亚的新冠疫情风险与应对措施。
BMJ. 2020 Mar 25;368:m1190. doi: 10.1136/bmj.m1190.
6
Covid-19 exposes weaknesses in European response to outbreaks.新冠疫情暴露了欧洲应对疫情爆发方面的弱点。
BMJ. 2020 Mar 18;368:m1075. doi: 10.1136/bmj.m1075.
7
The Novel Coronavirus Originating in Wuhan, China: Challenges for Global Health Governance.源自中国武汉的新型冠状病毒：全球卫生治理面临的挑战
JAMA. 2020 Feb 25;323(8):709-710. doi: 10.1001/jama.2020.1097.
8
Are high-performing health systems resilient against the COVID-19 epidemic?高绩效的卫生系统对新冠疫情有抵御能力吗？
Lancet. 2020 Mar 14;395(10227):848-850. doi: 10.1016/S0140-6736(20)30551-1. Epub 2020 Mar 6.
9
Resource Allocation in COVID-19 Research: Which Trials? Which Patients?2019冠状病毒病研究中的资源分配：哪些试验？哪些患者？
Am J Bioeth. 2020 Jul;20(7):86-88. doi: 10.1080/15265161.2020.1779392.
10
Public Masking: An Urgent Need to Revise Global Policies to Protect against COVID-19.公众佩戴口罩：迫切需要修订全球政策以防范新冠病毒。
Am J Trop Med Hyg. 2020 Jun;102(6):1160-1161. doi: 10.4269/ajtmh.20-0305.

引用本文的文献

1
Regulatory agilities impacting review timelines for Pfizer/BioNTech's BNT162b2 mRNA COVID-19 vaccine: a retrospective study.影响辉瑞/生物科技公司BNT162b2 mRNA新冠疫苗审评时间的监管灵活性：一项回顾性研究
Front Med (Lausanne). 2023 Nov 8;10:1275817. doi: 10.3389/fmed.2023.1275817. eCollection 2023.
2
Implementing an outpatient clinical trial on COVID-19 treatment in an emergency epidemic context: a mixed methods study among operational and research stakeholders within the Coverage trial, Bordeaux (France).在紧急疫情背景下开展一项关于新冠肺炎治疗的门诊临床试验：法国波尔多覆盖试验中运营和研究利益相关者的混合方法研究
Arch Public Health. 2022 Dec 3;80(1):245. doi: 10.1186/s13690-022-00999-9.
3
Regulatory reliance for convergence and harmonisation in the medical device space in Asia-Pacific.
亚太地区医疗器械领域趋同与协调的监管依赖
BMJ Glob Health. 2022 Aug;7(8). doi: 10.1136/bmjgh-2022-009798.
4
Science, Innovation, and Society in the Age of Pandemics: Reflections From the Inaugural Sir Alasdair Breckenridge Lecture.大流行时代的科学、创新与社会：首届阿拉斯代尔·布雷肯里奇爵士讲座的思考
Clin Pharmacol Ther. 2022 Mar;111(3):548-550. doi: 10.1002/cpt.2468. Epub 2021 Nov 11.
5
Countermeasures against COVID-19: how to navigate medical practice through a nascent, evolving evidence base - a European multicentre mixed methods study.应对 COVID-19 的对策：如何在新兴的、不断发展的证据基础上驾驭医疗实践——一项欧洲多中心混合方法研究。
BMJ Open. 2021 Feb 17;11(2):e043015. doi: 10.1136/bmjopen-2020-043015.
6
Regulatory Agilities in the Time of COVID-19: Overview, Trends, and Opportunities.《COVID-19 时期的监管动态：概述、趋势与机遇》。
Clin Ther. 2021 Jan;43(1):124-139. doi: 10.1016/j.clinthera.2020.11.015. Epub 2020 Nov 30.
7
The COVID-19 crisis as an opportunity to strengthen global regulatory coordination for sustained enhanced access to diagnostics and therapeutics.将新冠疫情危机作为加强全球监管协调的契机，以持续扩大诊断和治疗手段的可及性。
Clin Transl Sci. 2021 May;14(3):777-780. doi: 10.1111/cts.12954. Epub 2021 Jan 21.
8
Resilient managed competition during pandemics: lessons from the Italian experience during COVID-19.大流行期间有韧性的管理式竞争：COVID-19 期间意大利经验的教训。
Health Econ Policy Law. 2022 Apr;17(2):212-219. doi: 10.1017/S1744133120000353. Epub 2020 Sep 4.
9
Roadblocks and COVID-19: Hope and Strict Control.障碍与新冠疫情：希望与严格管控
Disaster Med Public Health Prep. 2020 Jun;14(3):e33. doi: 10.1017/dmp.2020.208. Epub 2020 Jun 24.